D. Boral Capital Maintains Buy on Pulmonx, Maintains $14 Price Target

Benzinga · 11/13/2025 13:59
D. Boral Capital analyst Jason Kolbert maintains Pulmonx (NASDAQ:LUNG) with a Buy and maintains $14 price target.